Loading clinical trials...
Loading clinical trials...
A study to assess, in a two-arm open-label cluster randomized clinical trial, the efficacy of a 5-day course of LPV/r treatment in preventing COVID-19 in asymptomatic individuals exposed to a SARS-CoV...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Calmy Alexandra
NCT05160766 · Prevention of COVID-19
NCT05198063 · Prevention of COVID-19
NCT04646590 · Prevention of COVID-19, Safety and Efficacy
Instituto Nacional de Infectiologia Evandro Chagas, Fiocruz
Rio de Janeiro
Universitätsspital Basel and SwissTPH
Basel
Hôpitaux Universitaires de Genève
Geneva
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions